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Background: Magnitudes, geographic and racial variation in trends in coronary heart disease (CHD) mortality
within the US require updating for health services and health disparities research. Therefore the aim of this study is
to present data on these trends through 2007.
Methods: Data for CHD were analyzed using the US mortality files for 1999–2007 obtained from the US Centers for
Disease Control and Prevention. Age-adjusted annual death rates were computed for non-Hispanic African
Americans (AA) and European Americans (EA) aged 35–84 years. The direct method was used to standardize rates
by age, using the 2000 US standard population. Joinpoint regression models were used to evaluate trends,
expressed as annual percent change (APC).
Results: For both AA men and women the magnitude in CHD mortality is higher compared to EA men and
women, respectively. Between 1999 and 2007 the rate declined both in AA and in EA of both sexes in every
geographic division; however, relative declines varied. For example, among men, relative average annual declines
ranged from 3.2% to 4.7% in AA and from 4.4% to 5.5% in EA among geographic divisions. In women, rates
declined more in later years of the decade and in women over 54 years. In 2007, age-adjusted death rate per
100,000 for CHD ranged from 93 in EA women in New England to 345 in AA men in the East North Central
division. In EA, areas near the Ohio and lower Mississippi Rivers had above average rates. Disparities in trends by
urbanization level were also found. For AA in the East North Central division, the APC was similar in large central
metro (−4.2), large fringe metro (−4.3), medium metro urbanization strata (−4.4), and small metro (−3.9). APC was
somewhat higher in the micropolitan/non-metro (−5.3), and especially the non-core/non-metro (−6.5). For EA in the
East South Central division, the APC was higher in large central metro (−5.3), large fringe metro (−4.3) and medium
metro urbanization strata (−5.1) than in small metro (−3.8), micropolitan/non-metro (−4.0), and non-core/non-metro
(−3.3) urbanization strata.
Conclusions: Between 1999 and 2007, the level and rate of decline in CHD mortality displayed persistent
disparities. Declines were greater in EA than AA racial groups. Rates were greater in the Ohio and Mississippi River
than other geographic regions.
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In 2009, despite a long-term decline in death rates, coronary
heart disease (CHD) was the leading cause of death in the
US [1-4]. Although reductions in gender disparities in CHD
mortality have been noted [5], disparities in CHD mortality
based on race/ethnicity have remained largely unchanged
[6], and disparities in the morbidity of CHD appear to be in-
creasing [7]. Many publications have examined the decline
in CHD mortality in the US prior to 2000, but relatively few
have detailed both racial and geographic variation [1,8-20].
The Healthy People 2010 Initiative set the goals of reducing
the CHD mortality rate by 20 percent between 2000 and
2010 and reducing disparities in CHD mortality. The
Healthy People 2010 objectives of reducing death rates to
162 deaths per 100,000 populations for CHD were met in
2004. However, despite the overall decrease in CHD death
rates, the target death rates were not met for two subpopu-
lations: blacks and men [3]. Two out of the four overarching
goals of Healthy People 2020 are: 1) achieve health equity,
eliminate disparities, and improve the health of all groups;
and; 2) Examining and monitoring the distribution of death
rates provides the requisite information for focusing on the
groups most in need of early intervention to eliminate pre-
ventable disease, disability, and premature death and to im-
prove the health of all groups [4]. Magnitudes, geographic
and racial variation in trends in CHD mortality within the
US require frequent updating for health services and health
disparities research.
Accordingly, this report presents CHD mortality
trends between 1999–2007 among non-Hispanic blacks
and whites aged 35–84 years and geographic and racial
variation in CHD mortality trends.
Materials and methods
Deaths in 1999–2007 with coronary heart disease (Inter-
national Classification of Disease 10th revision [ICD-10]
codes I20-I25 (1999–2007) as underlying cause were
enumerated [20]. Data available for public use from
National Vital Statistics System (NVSS), files provided the
underlying cause of death and demographic data on dece-
dents [20]. The underlying cause of death is the disease
(or injury) that initiated the sequence of events leading dir-
ectly to death. For non-Hispanic African Americans (AA)
and European Americans (EA), age-adjusted death rates
per 100,000 using the 2000 US standard population with
95% confidence intervals (CI) were computed for persons
aged 35–84 years using standard methods [20]. Following
policy of the NVSS, years and areas were combined to
avoid producing death rates considered unreliable, i.e.
when the death count is less than 20. Variation by sex and
race in annual percentage change (APC) between 1999
and 2007 were assessed using JoinPoint software [21].
Joinpoint is statistical software for the analysis of trends
using joinpoint models, that is, models where severaldifferent lines are connected together at the "joinpoints".
This enables the user to test that an apparent change in
trend is statistically significant. The tests of significance
use a Monte Carlo Permutation method. Numbers of U.S.
residents for the period 1999–2007 were obtained from
the U.S. Bureau of the Census and used to calculate death
rates per 100,000 populations. Bridged-race Census esti-
mates were used as denominators for groups defined by
race and Hispanic origin. Urbanization levels and Census
divisions are defined in Additional file 1: Table S1 [22].
Results
In 2007 at ages 35–84, US age-adjusted CHD death rates
per 100,000 (95% CI) were as follows: women EA 111
(110–112), AA 171 (168–174); men EA 238 (237–239), AA
312 (307–316). Examination of annual percent change
(APC) and US age-adjusted CHD death rates between 1999
and 2007 for women and men at ages 35–84 yrs revealed
that rates declined for AA and EA men at ages 35–84, and
in each age subgroup (Table 1). In both EA and AA
women, the rates declined more rapidly in later years com-
pared to the earlier years of the decade. In women, APC
was greater above age 54 than at 35–54 years, which the
APC for EA women barely different from 0 (Table 1).
Table 2 shows states with in order of decreasing age
adjusted CHD mortality rates for AA in 2005–2007,
while Additional file 2: Tables S2 and Additional file 3:
Table S3 show state rankings for EA. Relative variation
was greatest in AA men and least in AA women. For the
entire period 1999–2007, Figures 1 and 2 show that high
death rates for EA men and women tended to cluster
around the Ohio and lower Mississippi Rivers and low
rates in Rocky Mountains (Additional file 2: Tables S2
and Additional file 3: Table S3). Clustering of high rates
for both AA men and women was seen in the East
North Central, West South Central states, Middle Atlan-
tic States and California and low rates in South Atlantic
and East South Central states (see Additional file 4:
Figures S1 and Additional file 5: Figure S2. The ratio of
the 90th to the 10th percentile of rates in states for EA
and AA combined was 1.67 in 1999 and 1.76 in 2007
(1.61 and 1.67 resp. in EA only).
In 1999–2007 rates declined in all the nine US Census
divisions (Table 3). Relative declines tended to be greatest
in the New England, Mountain and Pacific divisions. Vari-
ation in rate of decline was greater in AA than in EA. The
greatest relative declines were in AA women in the East
South Central and New England divisions and the smallest
relative declines occurred in AA males in the Pacific, Mid-
Atlantic and North Central divisions.
For AA within the Mid-Atlantic, East North Central and
Pacific divisions where over 6 million AA aged 35–84
resided, age-adjusted rates for 1999–2007 combined were
highest in large, central metropolitan (LCM) areas, e.g. Mid-
Table 1 Annual percent change age-adjusted rates of mortality from coronary heart disease per 100,000 by race in
non-Hispanic women and men aged 35-84+ years: United States, 1999-2007
Characterstic Year AA women EA women AA men EA men
APC(CI)35-84Y 1999-2007 - - −4.0 (−4.6,-3.4) −4.8 (−5.1,-4.5)
Rate 1999 - - 329 346
Rate 2007 - - 246 240
APC(CI)35-84Y 2003-2007 - −6.2 (−7.2, -5.1) - -
Rate 2003 - 143 - -
Rate 2007 - 111 - -
APC(CI)35-84Y 1999-2003 - −4.5 (−5.5,-3.5) - -
Rate 1999 - 172 - -
Rate 2003 - 143 - -
APC(CI)35-84Y 2002-2007 −6.3 (−7.0,-5.6) - - -
Rate 2002 237 - - -
Rate 2007 171 - - -
APC(CI)35-84Y 1999-2002 −3.7 (−5.2, -2.1) - - -
Rate 1999 265 - - -
Rate 2002 237 - - -
APC(CI) 35-54Y 1999-2007 −3.2 (−3.9,-2.6) −0.8 (−1.4, -0.1) −2.6 (−3.2.-2.0) −2.1 (−2.4,-1.7)
APC(CI) 55-84Y 1999-2007 −5.7 (−6.3,-5.1) −5.7 (−6.2, -5.2) −4.3 (−4.9,-3.6) −5.2 (−5.5,-4.9)
APC(CI) >84Y 1999-2007 −5.2 (−6.2,-4.2) −5.9 (−6.5,-5.2) −6.1 (−6.8,-5.5) −5.2 (−5.7,-4.8)
AA, African American; EA, European American; APC, annual percent change; CI, 95% confidence interval; Y = ages in years.
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metro (LFM) 372 (366–379). In South Atlantic and East
South Central divisions, rates showed a similar pattern but
at somewhat lower levels e.g. South Atlantic LCM 369
(365–373) versus LFM 311 (307–315). In New England,
West North Central and West South Central division’s rates
were highest in the non-core (non-metropolitan) areas.
For EA within the New England, Mid-Atlantic, East
North Central and Pacific divisions, age-adjusted rates for
1999–2007 combined were highest in LCM areas, e.g.
Mid-Atlantic LCM 276 (95% CI 274–278) versus LFM
209 (208–210). In West North Central, South Atlantic,
East South Central and West South Central divisions rates
were highest in the non-core(non-metropolitan) divisions,
e.g. East South Central non-core(non-metropolitan) div-
ision 281 (278–284) versus LCM 212 (209–215).
Trends were examined by urbanization level in the East
North Central division for AA and the East South Central
division for EA, i.e. the divisions with highest rates. For
AA in the East North Central division, the APC was simi-
lar in large central metro (−4.2), large fringe metro (−4.3),
medium metro urbanization strata (−4.4), and small metro
(−3.9). The somewhat higher APC in the micropolitan/
non-metro (−5.3), and especially the non-core/non-metro
(−6.5) urbanization strata must be viewed with caution
due to much smaller annual numbers of deaths.
For EA in the East South Central division, the APC was
higher in large central metro (−5.3), large fringe metro(−4.3) and medium metro urbanization strata (−5.1) than
in small metro (−3.8), micropolitan/non-metro (−4.0), and
non-core/non-metro (−3.3) urbanization strata.
Discussion
The long-term decline in CHD mortality rates has contin-
ued during the first decade of the new century for major
demographic subgroups. However, the historic racial dis-
parities and substantial geographic disparities persist.
Hence, the Healthy People 2010 goal of a 20% decline be-
tween 2000 and 2010 likely will be met or exceeded
(2000–2007 all ages decline 33%), but little or no progress
towards the goal of elimination of racial or geographic
relative disparities during the decade is evident.
Many studies have documented the magnitude and the
important contributions of both improvements in health
care and improvements in population risk factor levels in
reducing CHD incidence rates and reducing case fatality
rates for acute myocardial infarction and long-term sur-
vival with CHD[1,3-5,8,13-18]. Combined US racial and
geographic variation in levels and trends in CHD mortal-
ity or morbidity has been the subject of a smaller number
of studies [1,8-19]. The causes of the large racial and geo-
graphic variation in CHD mortality have yet to be fully
identified [23-30]. Disparities in access to and quality of
therapeutic and preventive health care and socioeconomic
and cultural variation in lifestyles and risk factor levels are
thought to play important roles [29,30]. For example,
Table 2 States* with the highest and lowest age-adjusted
coronary heart disease mortality rate per 100,000 by sex
and race in non-Hispanic African Americans aged





































*Excludes states with 99 or fewer deaths in 2005–2007 for given group.
+Ratio of rate of state in first row to state in last row.
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tion produces have been well documented [31,32].
Early investigators noted high stroke mortality rates
among Americans in the southeastern coastal states. By
late 1980s, this “stroke belt” had dissipated in the south
eastern coastal areas and shifted to the Midwest regions ofthe Mississippi and Ohio River valleys [8]. CHD mortality
has shown a similar westward shift to the so called coron-
ary valley [9]. The increased cardiovascular disease (CVD)
mortality among blacks has been mainly confined to the
southern states (Mississippi River valley). Although
changes in regional profile of risk factors, local environ-
ment, and migration pattern may have played a role, re-
cent economic shifts in these areas may be the principal
reason for changes in disease rates [8]. Whereas southeast-
ern coastal areas have undergone considerable economic
development, the more westward regions have not kept
pace [8]. In Mississippi, one of the most economically and
educationally disadvantaged US states, CVD mortality has
risen among African Americans over the past two decades
while among whites there has been a decline [10]. Similar
patterns are also observed in the Northeast and the Mid-
west [11,12].
Our understanding of the existence in race/ethnic var-
iations in CHD disease burden comes from observed dif-
ferences in their rates and risk factors between
countries. For example, in the Seven Countries Study,
[33], low CHD rates were observed in Japan and the
Mediterranean countries, and high CHD rates in Finland
and the US. These differences were in large part
explained by differences in risk factors, but several fac-
tors may contribute to these observed differences, such
as diverse demographic profiles, environmental factors,
and genetic factors differences. These variations are per-
haps best illustrated by the knowledge gained from stud-
ies in migrants. The Ni-Hon-San study of Japanese
migrants revealed how blood cholesterol levels and CHD
rates rose from relatively low levels among those in
Japan, to intermediate levels in Honolulu, and to high
levels in San Francisco [34].
Comparison of Afro-Caribbeans, South Asians, and
Europeans in the UK indicate marked differences in cen-
tral obesity, glucose intolerance, hyperinsulinemia, and
related dyslipidemia, despite similar blood pressure, body
mass index, and total plasma cholesterol [35]. In Canada,
there are marked differences between different ethnic
groups in the prevalence and death rates from CHD, with
the highest rates being among those of European and
South Asian origin, but lowest among those of Chinese
origin [36], suggesting that the propensity to CHD may
vary in different ethnic groups.
Differences in the age-adjusted death rates vary widely
between European populations. Data from the World
Health Organization (WHO) indicate that the cardiovas-
cular disease mortality rate is 6-fold higher among men
and women in the Russian Federation compared with
people in France [37]. In 1996, the age-standardized
mortality rates for coronary heart disease (CHD) among
males in the Russian Federation was 390/100 000 com-
pared with 60/100 000 among males in France [37].
Figure 1 Age-adjusted rate per 100,000 resident population of death from coronary heart disease by county for European American
women aged 35–84 years: United States, 1999–2007. Yellow, 34.7-114.5; light orange 114.6-142.0; dark orange 142.1-172.2; red 172.4-407.2;
white vertical bars, suppressed due to small number of deaths; color diagonal bars, unreliable value.
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among women compared with men, similar variations
among women between countries also exist. Eastern
European countries such as the Ukraine, the Russian Feder-
ation, Hungary, and the Czech Republic have among the
highest and increasing CVD rates in the world, which is in
marked contrast to most economically stable European
countries where declines in CVD mortality rates have been
experienced over the past 30 years [38]. CVD amongFigure 2 Age-adjusted rate of death per 100,000 population from cor
35–84 years: United States, 1999–2007. Yellow 56.8-252.0; light orange 2
bars, suppressed due to small number of deaths; color diagonal bars, unrelEuropean populations is mainly attributable to classical risk
factors, namely diets high in saturated fats, elevated serum
cholesterol and blood pressure (BP), diabetes, and smoking
[39].
Strengths of this study include focus on the years
1999–2007 when only ICD-10 was in use, which pre-
cluded bias due to changes in ICD version [20]. Unlike
some previous studies, analyses were restricted to non-
Hispanics to avoid bias arising from misclassification ofonary heart disease by county for European American men aged
52.1-300.4; dark orange 300.6-356.3; red 356.4-743.4; white vertical
iable value.
Table 3 Annual percent change and selected age-adjusted
rates of mortality from coronary heart disease per 100,000
by Census division, sex and race in non-Hispanics aged
35–84 years: United States, 1999-2007
Division AA Women EA Women AA Men EA Men
New England
APC 1999-2007 −6.2 −5.9 −4.7 −5.5
Rate 1999 176 144 329 306
Rate 2007 111 93 230 202
Mid Atlantic
APC 1999-2007 −3.9 −5.4 −3.5 −4.9
Rate 1999 284 197 452 379
Rate 2007 203 124 345 259
E. N. Central
APC 1999-2007 −5.2 −5.6 −3.6 −5.0
Rate 1999 285 181 487 374
Rate 2007 187 113 352 248
W. N. Central
APC 1999-2007 −4.9 −5.3 −3.5 −4.8
Rate 1999 274 151 428 324
Rate 2007 175 95 319 217
S. Atlantic AAPC
APC 1999-2007 −6.1 −5.8 −4.7 −5.1
Rate 1999 238 165 395 344
Rate 2007 148 102 273 227
E. S. Central
APC 1999-2007 −6.4 −4.5 −4.1 −4.4
Rate 1999 266 189 434 398
Rate 2007 162 132 309 276
W. S. Central
APC 1999-2007 −5.8 −4.6 −4.1 −4.5
Rate 1999 276 189 461 385
Rate 2007 172 130 332 267
Mountain
APC 1999-2007 −5.7 −4.8 −5.6 −4.6
Rate 1999 229 137 332 295
Rate 2007 140 89 193 196
Pacific
APC 1999-2007 −5.3 −5.5 −3.2 −4.8
Rate 1999 308 172 471 339
Rate 2007 195 107 346 224
AA, African American; EA, European American.
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the lack of information on racial and regional variation
in validity of CHD diagnoses from death certificates,
bias due to diagnostic misclassification cannot be
excluded as a possible contributor to variation [40]. Thevalidity of using age-adjusted rates for ages 65 yrs and
over may be a problem as rates are driven by oldest age
groups for CHD where diagnosis accuracy may be ques-
tionable. Results of trends in age-adjusted rates within
three age bands were performed for this reason. Ecolo-
gic analyses of clinical information for cases or data on
access to care or risk factor levels, socioeconomic and
health service variables in different geographic areas
could have confounded or mediated some of the results
but analysis of those variables was beyond the scope of
this study. More such efforts are needed to explain
observed racial and geographic patterns. Continued
monitoring of racial and geographic disparities will be
of especial importance in an era of health care system
changes.Conclusions
Between 1999 and 2007, the level and rate of decline in
CHD mortality displayed persistent disparities. Rates
were greater in the Ohio and Mississippi River than
other geographic regions. Declines were greater in EA
than AA racial groups.Additional files
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to the six urbanization levels of the 2006 NCHS Urban-Rural Classification.
Additional file 2: Table S2. Age-adjusted coronary heart disease
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men aged 35-84 years: United States, 2005-2007.
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population of death from coronary heart disease by state for African
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